VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas. BMC Cancer. 2015 Nov 14; 15:901.
View in:
PubMed
subject areas
Cell Differentiation
Cell Line, Tumor
Cell Movement
Cell Proliferation
Enzyme-Linked Immunosorbent Assay
Humans
Immunohistochemistry
Intercellular Signaling Peptides and Proteins
Liposarcoma
Neoplasm Invasiveness
Neoplasm Proteins
Proto-Oncogene Proteins
Receptor Protein-Tyrosine Kinases
authors with profiles
ALEXANDER LAZAR
KEILA ENITT TORRES